Group | n (eyes) | MGL (%) at different follow-up time |
---|
Baseline | 1 month | 3 months | 6 months | 9 months | 12 months |
---|
PC-PGA | 28 | 55.89 ± 4.05 | 56.21 ± 4.15 | 56.55 ± 4.16 | 57.14 ± 4.03 | 61.59 ± 4.00a | 63.03 ± 4.18a |
PF-PGA | 39 | 55.86 ± 7.07 | 56.10 ± 6.46 | 56.22 ± 6.38 | 56.30 ± 6.24 | 56.55 ± 6.29b | 57.02 ± 6.15b |
PC-PGA + DQS | 17 | 55.91 ± 5.36 | 56.11 ± 5.07 | 56.12 ± 5.12 | 56.20 ± 5.04 | 56.42 ± 4.95b | 57.16 ± 4.78b |
- Values are represented as mean ± SD
- ANOVA = analysis of variance; DQS = diquafosol; IOP = intraocular pressure; MGL = meibomian gland loss; PC-PGA = preservative-containing prostaglandin analogs; PC-PGA + DQS = preservative-containing prostaglandin analogs and diquafosol; PF-PGA = preservative-free prostaglandin analogs; SD = standard deviation
- aRepeated measures ANOVA with post hoc Bonferroni correction, P < 0.001, vs baseline in the same group
- bMultivariate ANOVA with post hoc Bonferroni correction, P < 0.01, vs PC-PGA group at the same follow-up time